Research Topics
Genomes and Genes | Stephen G SwisherSummaryAffiliation: The University of Texas Country: USA Publications
| Collaborators
|
Detail Information
Publications
A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246Stephen G Swisher
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Int J Radiat Oncol Biol Phys 82:1967-72. 2012..The strategy of definitive chemoradiation with selective surgical salvage in locoregionally advanced esophageal cancer was evaluated in a Phase II trial in Radiation Therapy Oncology Group (RTOG)-affiliated sites...
Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancerS G Swisher
Departments of Thoracic and Cardiovascular Surgery, Medical Informatics, Gastrointestinal Oncology, and Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
J Thorac Cardiovasc Surg 119:1126-32. 2000..We sought to evaluate the effect of operative volume, hospital size, and cancer specialization on morbidity, mortality, and hospital use after esophagectomy for cancer...
Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancerStephen G Swisher
Department of Thoracic Surgery, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Ann Thorac Surg 78:1152-60; discussion 1152-60. 2004....
Improved long-term outcome with chemoradiotherapy strategies in esophageal cancerStephen G Swisher
Department of Thoracic and Cardiovascular Surgery, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Ann Thorac Surg 90:892-8; discussion 898-9. 2010..We therefore reviewed sequential phase II/III trials performed at a single institution to assess the impact of preoperative chemotherapy versus preoperative C/RT strategies...
Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT)Stephen G Swisher
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Ann Surg 241:810-7; discussion 817-20. 2005..To determine the impact of pathologic response following preoperative chemoradiation (CRT) on the AJCC esophageal cancer staging system...
Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapyStephen G Swisher
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 9:93-101. 2003..We designed a prospective single arm Phase II study to evaluate the feasibility and mechanisms of apoptosis induction after Ad-p53 (INGN 201) gene transfer and radiation therapy in patients with non-small cell lung cancer...
Clinical update of Ad-p53 gene therapy for lung cancerStephen G Swisher
University of Texas, M D Anderson Cancer Center, Department of Thoracic and Cardiovascular Surgery, Box 445, Houston, TX 77030, USA
Surg Oncol Clin N Am 11:521-35. 2002..It is hoped that these efforts will ultimately lead to a novel mode of therapy to complement conventional chemotherapy, radiation therapy, and surgical treatment strategies...
Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancerStephen G Swisher
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 57:120-7. 2003..To evaluate the long-term outcome of chemotherapy, chemoradiotherapy, and surgery for patients with locoregionally advanced esophageal cancer...
p53 Gene therapy for lung cancerStephen G Swisher
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 445, Houston 77030, USA
Curr Oncol Rep 4:334-40. 2002..Further phase III studies are needed to determine if Ad-p53 will play a therapeutic role as a novel agent to treat non-small-cell lung cancer...
The supercharged microvascular jejunal interpositionStephen G Swisher
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Semin Thorac Cardiovasc Surg 19:56-65. 2007....
Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapyStephen G Swisher
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Thorac Cardiovasc Surg 123:175-83. 2002..A subset of these patients have local relapse without distant metastases and therefore have no other curative intent treatment option but salvage esophagectomy...
2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinomaStephen G Swisher
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 101:1776-85. 2004..Preliminary reports suggest that FDG-PET may be predictive of the response of esophageal carcinoma patients to preoperative CRT...
Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagusPooja R Rohatgi
Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 104:1349-55. 2005..Future investigations should focus on reducing the proportion of residual carcinoma and metastatic disease progression in patients with esophageal carcinoma...
The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapyArya Amini
Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Ann Thorac Surg 94:914-20. 2012..We assessed the role of consolidative therapies (postoperative radiation therapy and chemotherapy) for such patients...
Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiationTakashi Taketa
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Oncology 83:300-4. 2012..The literature on the outcome of such patients is sparse...
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancerXifeng Wu
Department of Epidemiology, Experimental Therapeutics, GI Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 24:3789-98. 2006..Understanding how specific genetic variants modify drug action pathways may provide informative blueprints for individualized chemotherapy...
Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinomaJulie G Izzo
Department of Experimental Therapeutics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 25:698-707. 2007..We hypothesized that CD1 A870 allele would be associated with higher CD1 protein expression, and increased genomic instability during EAC evolution, leading to more aggressive phenotype...
Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junctionJaffer A Ajani
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
Cancer 100:2347-54. 2004..Patients with localized esophageal carcinoma often develop locoregional and distant disease recurrence. The current study investigated the outcome of a new chemotherapy combination as induction therapy before chemoradiotherapy...
The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiationYan Gu
Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 106:1017-25. 2006..The authors suggest modification of the tumor-lymph node-metastasis (TNM) staging classification (ypTNM) to include the number of positive LNs in the ypN1 category...
Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagusHeta Javeri
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 113:1302-8. 2008..Whether the type of therapy influences the outcomes remains largely unanswered. It is hypothesized that induction chemotherapy (IC) or the type of cytotoxics used would not influence patient outcomes...
Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junctionJaffer A Ajani
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Cancer 116:1656-63. 2010..It was hypothesized that chemoradiotherapy with fluoropyrimidine, taxane, and camptothecin would have preserved or improved efficacy with no compromise in safety...
Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcomeKim L Wang
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Cancer 109:658-67. 2007..It is not known whether EGFR plays a similar role in esophageal and EGJ adenocarcinomas...
Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidityDavid C Rice
Department of Thoracic and Cardiovascular Surgery, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Ann Thorac Surg 79:391-7; discussionn 391-7. 2005..Preoperative chemotherapy and radiation therapy are often administered to patients with esophageal cancer. Despite an aging population, little data exist regarding feasibility of preoperative therapy in elderly patients...
Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapyApar Pataer
Departments of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Thorac Oncol 7:825-32. 2012....
Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parametersHoon K Lee
Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 57:1317-22. 2003..Radiotherapy techniques that decrease the volume of lung receiving low radiation doses may significantly reduce the risk of this potentially life-threatening complication...
Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiationHeta Javeri
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 115:624-30. 2009..The authors evaluated initial standardized unit value (iSUV) of 18F-fluoro-2-deoxy-D-glucose positron emission tomography and its association with overall survival and the degree of pathologic response after surgery...
The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinomaSantosh B Murthy
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Oncology 78:316-22. 2010..We hypothesized that the standardized uptake value (SUV) of positron emission tomography (PET) after chemoradiation would define the clinical outcome in patients...
Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junctionKazumasa Fujitani
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Unit 444, P.O. Box 301402, Houston, TX 77230-1402, USA
Ann Surg Oncol 14:1305-11. 2007....
Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junctionKazumasa Fujitani
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Ann Surg Oncol 14:2010-7. 2007....
Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imagingJeremy J Erasmus
Department of Diagnostic Imaging, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
J Thorac Oncol 1:478-86. 2006..We evaluated the use of integrated computed tomography (CT)-PET among patients with esophageal cancer being considered for resection after CRT...
Omental reinforcement of the thoracic esophagogastric anastomosis: An analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomyBoris Sepesi
Department of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, Houston, Tex
J Thorac Cardiovasc Surg 144:1146-51. 2012..An uncontained thoracic anastomotic leak may cause severe morbidity or mortality. Thoracic transposition of an omental flap along with the gastric conduit may decrease leak incidence, severity, or need for reoperations after esophagectomy...
Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patientsZhongxing Liao
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 60:1484-93. 2004..To evaluate the effect of surgical resection on the outcome of patients with clinical Stage II or III cancer of the esophagus treated with concurrent chemoradiotherapy...
Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinomaPutao Cen
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Cancer 112:1020-7. 2008..The authors hypothesized that LVI status would subclassify T1b cancers and facilitate new therapeutic strategies...
The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinomaS Chris Malaisrie
Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 107:967-74. 2006..Overall survival and disease-free survival were increased in patients who received CCRT, especially in the subset of patients who had more advanced disease...
The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cellsKerry A Sieger
Introgen Therapeutics, Inc, Houston, TX 77030, USA
Mol Ther 9:355-67. 2004..Only full-length and ER-targeted MDA-7 elicited cell death in tumor cells. Thus in lung cancer cells, Ad-mda7 activates the UPR stress pathway and induces apoptosis via intracellular MDA-7 expression in the secretory pathway...
Adenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c releaseAbujiang Pataer
Section of Thoracic Molecular Oncology, Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, and Introgen Therapeutics Inc, Houston, TX 77030, USA
J Thorac Cardiovasc Surg 125:1328-35. 2003..This unique mechanism of action may allow treatment of patients with lung cancer resistant to mitochondrial permeability transition-dependent cell death processes...
Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcomeTsung Teh Wu
Department of Pathology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Am J Surg Pathol 31:58-64. 2007..The extent of residual carcinoma is a reliable and reproducible predictor of survival; this grading system may allow a novel and early means of comparing outcomes after different neoadjuvant treatment regimens...
Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapyFadi Braiteh
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Cancer 115:4450-8. 2009..For this study, the authors explored their institution's large surgical experience to examine the impact of age on long-term patient survival and surgical complications...
Video-assisted thoracoscopic versus open thoracotomy lobectomy in a cohort of 13,619 patientsRaja R Gopaldas
the Texas Heart Institute at St Luke s Episcopal Hospital, Houston, Texas, USA
Ann Thorac Surg 89:1563-70. 2010..However, the issue of whether VATS or open thoracotomy is better remains controversial. We compared outcomes of open and VATS lobectomy in a national database...
Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagusPooja R Rohatgi
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA
Int J Gastrointest Cancer 36:69-76. 2005..Frequent presence of malignant nodes in the resected specimens of ACA patients resulted in a shorter time-to-metastases suggesting that ACA patients need better systemic control...
Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinomaS Chris Malaisrie
Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Tex 77030, USA
J Thorac Cardiovasc Surg 131:65-72. 2006..These patients should be stratified in future multimodality trials. The investigation of induction chemotherapy before concurrent chemoradiotherapy might be warranted in this high-risk group of patients...
The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinomaHeta Javeri
Department of Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Cancer 115:5184-92. 2009..Analyses of dichotomized data are commonly reported. The authors analyzed percentage SUV decrease as both dichotomized and continuous variables...
Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapyJohn F Bruzzi
Division of Diagnostic Imaging, M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
Cancer 109:125-34. 2007....
Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinomaJeannelyn S Estrella
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA
Am J Surg Pathol 35:1045-53. 2011..EAC invasion into the space between duplicated MM confers a similar risk of lymph node metastasis and recurrence as those of intramucosal EAC, and LVI is the best predictor of lymph node status and RFS in pT1 EAC...
Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patientsElizabeth H Stephens
Methodist Hospital, Houston, TX, USA
J Am Coll Surg 212:821-6. 2011..We hypothesized that measurable progression after chemotherapy is a novel predictor of poor outcomes in sarcoma patients undergoing pulmonary metastasectomy...
Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivoStephan A Vorburger
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 444, Houston, Texas 77030-4009, USA
Mol Cancer Ther 4:1710-6. 2005..Taken together, these data suggest that E2F-1 gene therapy and PKR modulation might be a promising treatment strategy for these tumors that are highly resistant to conventional therapies...
Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinomaLucian R Chirieac
Department of Pathology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Clin Cancer Res 11:2229-36. 2005..04). CONCLUSIONS: Our study showed that patients with esophageal or EGJ adenocarcinoma who have signet-ring cell or mucinous histology benefited substantially from preoperative chemoradiation and esophagectomy...
Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinomaDavid Hong
Department of GI Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 104:1620-6. 2005..Baseline NPA (> 1), reflecting the regional nodal metastases, is an independent predictor of OS. Baseline PET may become a useful stratification factor in randomized trials and for individualizing therapy...
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinomaJulie G Izzo
Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA
J Clin Oncol 24:748-54. 2006..Additional understanding of NF-kappaB regulated pathways may uncover potential therapeutic targets...
Treatment outcomes of resected esophageal cancerWayne Hofstetter
Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
Ann Surg 236:376-84; discussion 384-5. 2002..The increased use of preoperative chemoradiation, better preoperative staging, and other time-dependent factors may have contributed to the observed increase in survival...
Does the timing of esophagectomy after chemoradiation affect outcome?Jae Y Kim
Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Ann Thorac Surg 93:207-12; discussion 212-3. 2012..However, there are theoretical concerns that waiting longer after radiation may lead to a more difficult operation and more complications. The optimal timing of esophagectomy after CXRT is unknown...
Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete responsePooja Rohatgi
Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 104:2365-72. 2005..Chemoradiotherapy as primary therapy for patients with Stage I esophageal carcinoma warrants investigation as a means to preserve their esophagus...
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiationLucian R Chirieac
Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 103:1347-55. 2005..The findings in the current study supported the concept of downstaging by preoperative therapy...
Role for the double-stranded RNA-activated protein kinase PKR in Ad-TNF-alpha gene therapy in esophageal cancerUrs von Holzen
Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
Surgery 138:261-8. 2005..Strategies to enhance PKR upregulation may allow increased Ad-TNF-alpha antitumoral activity in the treatment of esophageal cancer...
Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinomaMahmoud Goodarzi
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Mod Pathol 22:1612-21. 2009..In addition, phosphorylated histone H3 is a potential supportive marker to histology in differentiating low-grade dysplasia from indefinite for dysplasia and high-grade dysplasia from adenocarcinoma in the mucosal biopsy samples...
Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKRAbujiang Pataer
Department of Thoracic and Cardiovascular Surgery, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 445, Houston, TX 77030, USA
Mol Ther 11:717-23. 2005....
The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiationKim L Wang
Departments of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
Cancer 107:1467-74. 2006..The presence of NE differentiation in residual tumor was associated with poor survival after preoperative neoadjuvant therapy...
Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesotheliomaDavid C Rice
Department of Thoracic and Cardiovascular Surgery, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA
Ann Thorac Surg 84:1685-92; discussion 1692-3. 2007..To improve local control, we have used intensity-modulated radiation therapy (IMRT) as it allows better dose distribution to regions at risk of recurrence as well as reduced radiation to surrounding organs...
Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapyPooja R Rohatgi
Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 106:552-8. 2006..CONCLUSIONS: The results of the current study suggest that the clinical biology of SCC and ACA is different after CTRT. An investigation of molecular and patient genetics is needed to improve therapy...
Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiationZhongxing Liao
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Int J Radiat Oncol Biol Phys 64:700-8. 2006..To test the hypothesis that TS3'UTR polymorphisms predict outcomes in 146 Caucasian patients with esophageal adenocarcinoma treated with preoperative 5-fluorouracil-based chemoradiation...
Prognostic significance of differentially expressed miRNAs in esophageal cancerYuxin Hu
Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX77030, USA
Int J Cancer 128:132-43. 2011..Our data indicate that further evaluation of miR-30e and miR-16-2 as prognostic biomarkers is warranted in patients with esophageal adenocarcinoma. In addition, the role of miR-34a in esophageal cancer also warrants further study...
3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC)Sai Yendamuri
Department of Thoracic Surgery, Roswell Park Cancer Institute, Buffalo, New York, USA
J Thorac Oncol 3:979-84. 2008..1 and 10q22.3 by fluorescent in situ hybridization (FISH) and to examine their distribution in different areas of the airway in patients with non-small cell lung cancer...
Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinomaLixia Liu
Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
Am J Surg Pathol 29:1079-85. 2005....
Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomographySrikrishna V Patnana
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 116:4487-94. 2010..High SUV (HSUV) after chemoradiation portends a poor prognosis. The authors retrospectively examined the role of surgery in patients with HSUV after chemoradiation...
Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experiencePanteleimon Kountourakis
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 117:925-30. 2011..This study analyzed the largest series of consecutive cT2N0M0 esophageal cancer patients treated with preoperative chemoradiotherapy...
Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysisJian Gu
Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Unit 1340, 1155 Pressler Boulevard, Houston, TX 77030, USA
Cancer Prev Res (Phila) 3:1176-86. 2010..8q24 (containing Myc) and 8p23.1 (containing CTSB) were the two most frequently amplified regions. In addition, a significant trend toward increasing amplification was associated with higher progression stage...
The double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kappaB and Akt activationUrs von Holzen
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 13:6032-9. 2007..There have been no reports to date about the role of PKR in radiation sensitivity...
The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institutionLinda W Martin
Departments of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Tex, USA
J Thorac Cardiovasc Surg 130:1601-10. 2005..23-2.04; P < .001) were independent predictors of poor survival. CONCLUSIONS: The use of multimodality therapy appears to contribute to improved outcomes over time in patients with resected stage IIIA (N2) non-small cell lung cancer...
A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patientsPuja Gaur
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Ann Surg 252:611-7. 2010..We, therefore, constructed a nomogram to predict the risk of pN1 prior to surgical resection and externally validated the clinical utility of the model...
Superior sulcus tumors with vertebral body involvement: a multimodality approachWilliam D Bolton
Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Tex 77030, USA
J Thorac Cardiovasc Surg 137:1379-87. 2009..We have previously documented a 2-year survival of 54% in patients treated with a multimodality approach. This work builds on our previous experience and examines the long-term outcomes...
Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagusDipen M Maru
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Am J Surg Pathol 32:1404-11. 2008..031). There was no difference in prognosis between patients with large-cell NEC and those with small-cell neuroendocrine carcinoma. Esophageal NEC is an aggressive tumor, and patients with mix NEC have better outcome...
Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesotheliomaCharles Lu
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
J Clin Oncol 23:3495-501. 2005..The optimal role of intrapleural L-NDDP therapy currently remains to be determined...
Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR)Abujiang Pataer
Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Cancer Res 62:2239-43. 2002..Additionally, PKR null but not wild-type fibroblasts are resistant to Ad-mda7-induced apoptosis. These results suggest that the activation of PKR and its downstream targets may be a critical pathway for Ad-mda7-mediated apoptosis...
Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosisJian Gu
Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Oncogene 23:1300-7. 2004..Our data suggest that Ad-p53 induces the expression of a variety of proapoptotic genes and that lack of induction in one of these genes does not block Ad/p53-mediated cell killing in human lung cancer cells...
Positron emission tomography imaging in nonsmall-cell lung cancerJeremy J Erasmus
Division of Diagnostic Imaging, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 110:2155-68. 2007..The article discusses the diagnosis, staging, and assessment of treatment response and prognosis with an emphasis on the appropriate clinical use of PET in management...
Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare CohortGrace L Smith
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
Int J Radiat Oncol Biol Phys 74:482-9. 2009..Optimal management of elderly patients with nonmetastatic esophageal cancer is unclear. Outcomes data after locoregional treatment are lacking for this group...
MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagusDipen M Maru
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA
Am J Pathol 174:1940-8. 2009..In conclusion, this study identified miR-196a as a potential marker of progression of BE and KRT5, SPRR2C, and S100A9 as its targets...
Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcomeKim L Wang
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
Clin Cancer Res 12:4598-604. 2006..However, the role of ANXA1 in esophageal adenocarcinoma is unclear. Our goal was to evaluate ANXA1 expression and determine its prognostic significance in adenocarcinoma of the esophagus and esophagogastric junction...
Management of intrathoracic leaks following esophagectomyLinda W Martin
Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Unit 445, PO Box 301402, Houston, TX 77230-1402, USA
Adv Surg 40:173-90. 2006..With further advances in surgical technique, critical care, and multimodality treatment, this trend is likely to continue...
Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal refluxBanke Agarwal
Department of Gastrointestinal Medicine and Nutrition, M D Anderson Cancer Center, Houston, Texas, USA
Ann Thorac Surg 79:1716-23. 2005..In this study, we investigated potential differences in clinical outcomes in esophageal adenocarcinoma patients based on the presence of identifiable Barrett's mucosa and/or history of symptomatic GERD...
Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinomaPutao Cen
Department of Gastrointestinal Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 112:503-10. 2008..It was hypothesized that endoscopic ultrasonography (EUS) in concert with detailed histopathologic evaluation would identify low-risk cancers for an appropriate but organ-preserving strategy...
Prognosis and reevaluation of lung cancer by positron emission tomography imagingJeremy J Erasmus
M D Anderson Cancer Center, Division of Diagnostic Imaging, Houston, TX 77030, USA
Proc Am Thorac Soc 6:171-9. 2009..This article will discuss the assessment of prognosis and treatment response in patients with non-small cell lung cancer using FDG-PET, and will emphasize potential advantages and limitations in clinical management...
Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan statusMin P Kim
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Ann Thorac Surg 90:884-90; discussion 890-1. 2010..We hypothesized that these patients would have similar survival to patients with incomplete response to therapy...
Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancerSai Yendamuri
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
J Thorac Oncol 2:1022-8. 2007..In this study, we retrospectively compared the outcome of patients treated with wedge resection or three-dimensional (3-D) conformal radiation therapy, the most common treatment modalities used for such high-risk patients...
Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosisStephan A Vorburger
Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, TX 77030, USA
Oncogene 21:6278-88. 2002..We conclude that an important pathway of E2F-1-mediated apoptosis is dependent on PKR activation and does not require p53 or p73...
Extended surgical staging for potentially resectable malignant pleural mesotheliomaDavid C Rice
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Ann Thorac Surg 80:1988-92; discussion 1992-3. 2005..We evaluated the role of extended surgical staging procedures, which generally includes a combination of laparoscopy, peritoneal lavage, and mediastinoscopy, to more precisely stage patients with MPM...
Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstructionAnthony J Ascioti
Department of Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Tex 77030, USA
J Thorac Cardiovasc Surg 130:1391-8. 2005..Functional outcomes are excellent, despite the severity of disease and technical challenges in this patient population...
Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessationAra A Vaporciyan
Department of Thoracic and Cardiovascular Surgery and Medical Informatics, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
Ann Thorac Surg 73:420-5; discussion 425-6. 2002..The purpose of this study was to identify preoperative and perioperative factors associated with the development of MPEs after pneumonectomy to help predict which patients are at increased risk for MPEs...
Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patientsAbujiang Pataer
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Clin Cancer Res 16:5522-8. 2010..To explore the role of PKR in human lung cancer, we evaluated the expression of PKR in tissue microarray (TMA) specimens from both non-small cell lung cancer (NSCLC) and normal human bronchial epithelium tissue...
Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesotheliomaDavid C Rice
Department of Thoracic and Cardiovascular Surgery, The University of Texas, M D Anderson Cancer Center, Houston, Texas 77030, USA
Ann Thorac Surg 88:862-8; discussion 868-9. 2009....
Proposed modification of nodal status in AJCC esophageal cancer staging systemWayne Hofstetter
Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Ann Thorac Surg 84:365-73; discussion 374-5. 2007..Recent reports suggest that the number of lymph nodes involved is also an important factor. We reviewed our esophageal experience to propose an improved nodal staging system...
Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiationRajyalakshmi Luthra
Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77054, USA
J Clin Oncol 24:259-67. 2006..Currently, however, there are no tools to help select optimum therapy. We hypothesized that gene expression profiling could provide clues and biomarkers for selection of therapy...
Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killingAbujiang Pataer
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Mol Cancer Ther 7:2528-35. 2008..These findings suggest that vectors targeting the ER (Ad-ER-mda7) may be more effective in cancer gene therapy possibly through more effective induction or ER stress pathways...
Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivityAbujiang Pataer
Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Cancer Biol Ther 8:245-52. 2009..Our results suggest a rationale to develop therapeutic strategies that target PKR signaling in human cancer cells...
Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control studyRuth L Katz
Department of Pathology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
Clin Cancer Res 16:3976-87. 2010....
Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survivalDipen M Maru
Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 115:1576-85. 2009..It was unclear whether this difference was due to loss of heterozygosity (LOH) or to other genetic alterations at this locus...
Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patientsAra A Vaporciyan
Department of Thoracic and Cardiovascular Surgery, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 445, Houston, TX 77030, USA
J Thorac Cardiovasc Surg 127:779-86. 2004..The purpose of this study was to identify risk factors associated with the onset of atrial fibrillation after thoracic surgery to allow more targeted interventions in patients with the highest risk...
Development of Ad-mda7/IL-24-resistant lung cancer cell linesAbujiang Pataer
Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Cancer Biol Ther 7:103-8. 2008..Together, these in vitro findings indicate that an antiapoptotic mechanism may underlie Ad-mda7 resistance and that such resistance can be overcome by addition of 17AAG. Further investigations along these lines are warranted...
Esophageal Cancer Clinical Practice GuidelinesJaffer Ajani
J Natl Compr Canc Netw 4:328-47. 2006
For localized gastroesophageal cancer, you give chemoradiation before surgery, but then what happens?Jaffer A Ajani
J Clin Oncol 25:4315-6. 2007
Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinomaSusan C Abraham
Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA
Am J Surg Pathol 31:1719-25. 2007..The 17% rate of angiolymphatic invasion and 10% rate of lymph node metastases in our patients with invasion into duplicated MM suggest that these tumors can behave aggressively despite their technically intramucosal location...
